Position in CRBU
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$6,843,673
-$3,005,063 QoQ
Shares Held
4,304,198
+1.8% QoQ
Ownership
4.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 12.083970114757731.ToString("F0")%
None 87.91602988524227.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,461,655 across 449 Biotechnology names. CRBU ranks #242 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in CRBU
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6,843,673 | 4,304,198 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,848,736 | 4,226,926 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $5,153,230 | 4,089,866 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $4,128,614 | 4,522,032 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $7,259,056 | 4,565,445 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,051,804 | 4,618,268 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,453,316 | 4,544,706 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,129,485 | 4,110,795 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $22,702,510 | 3,962,044 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $18,269,880 | 3,822,151 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $10,880,980 | 2,560,231 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,838,182 | 2,606,061 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $16,203,761 | 2,580,217 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $26,938,663 | 2,553,428 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,818,528 | 1,992,363 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $18,374,263 | 2,001,554 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,800,043 | 914,516 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $22,351,867 | 936,400 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||